Introduction {#s1}
============

Nerve injury is a common clinical occurrence with a steadily increasing incidence worldwide, and may cause life-long disability and impair quality of life (Gu et al., [@B9]; Lee et al., [@B16]). Following nerve injury, axons in the distal nerve stump are separated from neuronal cell bodies, and undergo Wallerian degeneration (Coleman, [@B4]). In the peripheral nervous system, Wallerian degeneration is typically detectable within 1--3 days after injury. Morphological analysis of the distal stumps of injured peripheral nerves showed that axon starts to disintegrate within hours after injury; proliferating Schwann cells and macrophages then engulf and clear the axon and myelin debris about three days later (Geuna et al., [@B8]).

However, in mammal central nerves, Wallerian degeneration initiates much slower (Vargas and Barres, [@B27]). Additionally, Wallerian degeneration rarely occurs in many invertebrates and lower vertebrates (Bittner et al., [@B2], [@B3]). The different occurrences of Wallerian degeneration in different nervous systems make the role of Wallerian degeneration obscure, and thus many attempts have been made to investigate molecular basis underlying Wallerian degeneration.

A genetic study on the slow Wallerian degeneration (Wld^s^) mouse suggests that over-expression of nicotinamide mononucleotide adenylyltransferase fusion protein slows down Wallerian degeneration (Conforti et al., [@B5]; Mack et al., [@B20]). Another study reports that midkine knockout mice exhibit delayed axon degeneration and nerve regeneration following peripheral nerve injury (Sakakima et al., [@B24]). It has also been shown that activated potassium channel or inhibited sodium channel retards Wallerian degeneration of injured Drosophila axons (Mishra et al., [@B21]). And sterile alpha and TIR motif containing 1 (SARM1), a Toll-like receptor, has been demonstrated as an essential factor for triggering axon degeneration (Gerdts et al., [@B7]; Loreto et al., [@B19]). Despite these interesting findings, much is still unknown about the molecular mechanisms involved in Wallerian degeneration. A systems-level analysis may help to obtain a global understanding of Wallerian degeneration from the perspective of gene regulation.

Microarray analysis has been widely adopted to characterize many differentially expressed genes in normal versus experimental conditions. In our previous studies, we performed microarray to identify differentially expressed genes in the distal nerve stump following sciatic nerve injury (Yao et al., [@B30], [@B31]). By using the R software platform and the limma package, we were able to re-annotate and re-analyze these previous obtained microarray data. In an earlier study, we used Ingenuity Pathway Analysis (IPA) software program to analysis dynamic molecular changes in the injured distal nerve stump and gained some insights into Wallerian degeneration (Yu et al., [@B33]). In the current study, we made the joint use of Euclidean distance calculation, hierarchical clustering, principal component analysis (PCA), Gene ontology (GO) analysis, Kyoto Enrichment of Genes and Genomes (KEGG) pathway analysis, and IPA to further access genetic changes occurring during Wallerian degeneration.

Materials and methods {#s2}
=====================

Animal surgery
--------------

Adult male Sprague-Dawley (SD) rats were obtained from the Experimental Animal Center of Nantong University. All animal procedures were performed in accordance with Institutional Animal Care guideline of Nantong University and ethically approved by the Administration Committee of Experimental Animals, Jiangsu Province, China. Animals were anesthetized by injection of mixed narcotics (85 mg/kg trichloroacetaldehyde monohydrate, 42 mg/kg magnesium sulfate, and 17 mg/kg sodium pentobarbital), and underwent surgical transection of sciatic nerves as previously described (Yu et al., [@B32]). Briefly, the rat sciatic nerve was lifted through an incision on the lateral aspect of the mid-thigh of the left hind limb, and a 10-mm nerve segment was excised. Rats were then randomly divided into ten groups according to different time points post nerve injury (PNI). Rats were sacrificed by decapitation at 0.5, 1, 6, 12, and 24 h, 4 days, and 1, 2, 3, and 4 weeks PNI and the distal nerve stumps were collected, respectively. Rats in control group were sham-operated and immediately (designated as 0 h PNI) sacrificed by decapitation.

Microarray analysis
-------------------

Total RNA was extracted using Trizol (Life technologies, Carlsbed, CA) according to the manufacturer\'s instructions. Contaminating DNA was removed using RNeasy spin columns (Qiagen, Valencia, CA). The quality of isolated RNA samples was evaluated with an Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA) and the purified RNA was quantified using a NanoDrop ND-1000 spectrophotometer (Infinigen Biotechnology Inc., City of Industry, CA). An Affymetrix GeneChip Hybridization Oven 640 and Gene Array Scanner 3000 were used to perform microarray analysis. The R software (v.2.13.0) platform was applied to analyze the microarray data, and the limma (linear regression model) package was used to statistically analyze differentially expressed genes (Ritchie et al., [@B23]; Xu and Sun, [@B29]). The expression levels of mRNAs at each time point were compared with control. Genes having a fold change \> 2 or \< −2 and an adjusted *p* \< 0.05 were considered as differentially expressed.

Bioinformatic analysis
----------------------

Bioinformatic analysis tools, including Euclidean distance calculation, hierarchical clustering, PCA, GO, KEGG, and IPA, were applied to investigate differentially expressed genes PNI. Briefly, Euclidean distance calculation was performed using the HeatMapImage GenePattern module, and hierarchical clustering was computed with the Euclidean distance measure using the Hierarchical Clustering module from GenePattern. PCA was performed using "Population PCA" tool from Harvard Medical School. Database for Annotation, Visualization, and Integrated Discovery (DAVID) bioinformatic resources were used to systematically screen differentially expressed genes and to enrich significant GO categories and KEGG pathways (Huang da et al., [@B11],[@B12]). IPA was performed to identify and connect differentially expressed transcription factors.

Quantitative real time PCR (qPCR)
---------------------------------

A total amount of 0.5 μg RNA samples were used as templates and reverse transcribed to cDNA using the Prime-Script reagent Kit (TaKaRa, Dalian, China). PCR was performed using SYBR Green Premix Ex Taq (TaKaRa) with specific primer pairs on an Applied Biosystems Stepone real-time PCR System. The sequences of primer pairs were as follows: FOSL1 (forward) 5′-GACCTCTGACCTATCCCCAGT-3′ and (reverse) 5′-GTCGTAGCTCTGCTCTGTGT-3′; SS18L1 (forward) 5′-TGCAGAGCCCATGAGTCAAC-3′ and (reverse) 5′-TCATCCTCCAACTTGTCGGTC-3′; and GAPDH (forward) 5′-CCTTCATTGACCTCAACTACATG-3′ and (reverse) 5′-CTTCTCCATGGTGGTGAAGAC-3′. The thermal cycler program was as follows: 5 min at 95°C; 40 cycles of 30 s at 95°C, 45 s at anneal temperature, and 30 s at 72°C; and 5 min at 72°C. Relative quantification of mRNA was conducted using the comparative 2^−ΔΔCt^ method with GAPDH as the reference gene.

Statistical analysis
--------------------

All data are expressed as means ± SEM, and analyzed by using GraphPad Prism 6.0 (GraphPad Software, Inc.). Differences between groups were tested using Student\'s *t*-test or one-way ANOVA.

Results {#s3}
=======

Differentially expressed genes in the distal nerve stump following sciatic nerve transection
--------------------------------------------------------------------------------------------

Previous obtained microarray data (Yao et al., [@B30], [@B31]) were re-annotated and re-analyzed to identify the expression patterns of more than 30,000 genes. The expression levels of these genes at different time points PNI were compared with control (the expression level at 0 h PNI) and differentially expressed genes were determined according to fold change (\> 2 or \< −2) and adjusted *p* \< 0.05 (Table [S1](#SM1){ref-type="supplementary-material"}). Only a few genes were differentially expressed at 0.5 and 1 h PNI. More genes were differentially expressed at the ensuing time points PNI with a maximum number of differentially expressed genes being about 300 at 4 weeks PNI (Figure [1A](#F1){ref-type="fig"}). The most up-regulated gene was elevated for more than 13-folds (log~2~ ratio \> 3.7) while the most down-regulated gene was reduced to \~1/30 (log~2~ ratio \< −4.9). Top 10 up-regulated or down-regulated genes at each time point were listed in Table [1](#T1){ref-type="table"}.

![**Overview of the transcriptional pattern at the distal stumps following sciatic nerve transection. (A)** The bar graph showing the number of up-regulated (red) genes and down-regulated (green) genes at each time point following nerve transection as compared to control. **(B)** Euclidean distance heatmap, **(C)** hierarchical clustering, and **(D)** principal component analysis of differentially expressed genes at different time points following nerve transection.](fncel-11-00022-g0001){#F1}

###### 

**Top differentially expressed genes**.

  **Gene**         **Time after injury**                                                                                                                     
  ---------------- ----------------------- -------------- ------------ -------------- ------------ ---------------- -------------- ------------ ------------ --------------
  Up-regulated     IL6                     IL6            ERAL1        ERAL1          VGF          PCSK1            PCSK1          PCSK1        PCSK1        PCSK1
                   CXCL2                   PLAUR          PLAUR        MMP9           UCN2         TAF1D            SLC14A1        SLC14A1      KCNE1        KCNE1
                   GULO                    CCL20          KCNH7        IL1RN          MMP9         SLC14A1          MOXD1          MOXD1        SLC14A1      MOXD1
                                           CSF2           TAF1D        TAF1D          IL1RN        CACHD1           ST6GALNAC2     BDNF         MOXD1        SLC14A1
                                           CXCL3          RGD1309995   VGF            PTGER2       MMP9             MMP9           TAF1D        BDNF         BDNF
                                           IGSF21         IL1RN        RGD1309995     SLC14A1      ST6GALNAC2       TAF1D          REM2         MMP9         ARPP21
                                           EPHA4          SLC14A1      CXCL3          GMEB2        UCN2             BDNF           CACHD1       REM2         REM2
                                           CXCL2          MMP9         PTGER2         PCSK1        REM2             REM2           MMP9         CRYBB1       PPP1R17
                                           GRB7           IL6          UCN2           CLCA4L       XCL1             UCN2           ST6GALNAC2   GRIK1        GRIK1
                                           SLC16A13       PTGER2       PLAUR          RGD1305627   TTK              VGF            TCF23        BLDN6        TAF1D
  Down-regulated   SLC9A1                  UBTF           RFX4         PRICKLE2       SNRNP40      FOXA3            SLC7A14        CDH8         ZFP532       PVALB
                   STEAP2                  UBA7           ESRRG        LOC102546858   PCDH10       PDE6A            CHRNA3         CDK5R2       RGD1308742   GADL1
                   RGD1305014              LOC100911508   RGD1307235   MSX2           ESRRG        CCDC37           LOC102553190   RERE         AQP3         KCNA1
                   BTC                     RGD130514      PCDHB17      KNDC1          SFTPA1       LOC10090909409   LOC102553043   GNMT         KCNA1        PEX5L
                                           RECQL4         PRL8A2       DMRT2          SHROOM1      MYH3             TRIM9          PRRT4        PEX5L        LOC102553868
                                                          COL25A1      FSTL4          RGD1309108   PEX5L            C1QTNF4        PEX5L        F9           NRSN1
                                                          TAS2R121     RAPGEFL1       GRIA2        AAED1            LECT1          C1QTNF4      DRD5         PEX5L
                                                          SS18L1       PRRT2          DNAH7        PEX5L            UBQLN2         DCDC2        VOM1R100     GPR176
                                                          CLIC3        PRR15L         P2RX5        ST8SIA2          LOC679158      SEL1L3       RLBP1        VOM2R75
                                                          HPGD         ACVR1C         APBA2        RYR3             MCPT3          GALNT13      PEX5L        LMOD3

*The top 10 up-regulated and down-regulated genes based on fold change are listed*.

Three transcriptional phases of Wallerian degeneration
------------------------------------------------------

Cluster analysis was performed to compare the similarity in gene expression profiles among different time points PNI. Data from hierarchical clustering suggested that the gene expression profiles could be separated into two major groups: one at 0--24 h PNI and another at 24 h to 4 weeks PNI (Figure [1B](#F1){ref-type="fig"}). In the first major group, 0, 0.5, and 1 h PNI were similar and 6, 12, and 24 h PNI were similar. In the second major group, 4 days and 1 week PNI were similar and 2, 3, and 4 weeks were similar (Figure [1B](#F1){ref-type="fig"}). Euclidean distance matrix showed three different phases following nerve injury; namely 0, 0.5, and 1 h PNI for phase I; 6, 12, and 24 h PNI for phase II; 4 days, 1, 2, 3, and 4 weeks for phase III (Figure [1C](#F1){ref-type="fig"}). PCA analysis suggested that the 4 weeks PNI could be clustered into three different phases (Figure [1D](#F1){ref-type="fig"}). More detailed analysis indicated that within phase III, 4 days and 1 week PNI seemed to be closer, while 2, 3, and 4 weeks PNI seemed to be closer. This result was consistent with that from hierarchical clustering (Figures [1B,D](#F1){ref-type="fig"}). Since intra-phase differences were not as obvious as inter-phase differences, the time period of 0 h to 4 weeks PNI was arbitrarily divided into three phases for the sake of studying Wallerian degeneration.

Critical cellular components, molecular functions, and biological processes involved in Wallerian degeneration
--------------------------------------------------------------------------------------------------------------

DAVID database was used to annotate GO terms related to differentially expressed genes. The GO analysis helped to identify highly enriched categories of cellular components, molecular functions, and biological processes.

The enriched categories of cellular components at different time points PNI were identified with the *p*-value threshold set at 0.05 (Figure [2A](#F2){ref-type="fig"}). In brief, the categories of membrane fraction, insoluble fraction, and cell fraction were enriched at 1 h PNI, and the categories of extracellular region (part), extracellular space, and plasma membrane (part) were enriched starting from 6 h to 4 weeks PNI. To better analyze critical cellular components involved in nerve regeneration, the expression levels related to categories of cell soma, axon (part), dendrite, neuron projection, cytoskeleton, and synapse (part) were examined. The expression levels related to cell soma, axon (part), dendrite, and neuron projection were exponentially increased between 24 h and 4 days PNI and kept at a relatively high level at the ensuing time points PNI, while the expression changes related to synapse (part) seemed to lag several time points behind those related to other cellular components, showing a curved shape with alternate peaks and troughs (Figure [2B](#F2){ref-type="fig"}).

![**Enriched GO cellular component of differentially expressed genes. (A)** GO cellular components with a *p* \< 0.05 were labeled in red while cellular components with a *p* \> 0.05 were labeled in white. **(B)** The expression profiles of differentially expressed genes involved in major cellular components related with the nervous system.](fncel-11-00022-g0002){#F2}

Molecular functions related to differentially expressed genes were also identified by GO analysis according to *p* \< 0.05, and the results were shown in Figure [3A](#F3){ref-type="fig"}. The expression changes related to some categories that are important for nerve regeneration, including cytokine activity, growth factor activity, chemokines activity, chemokines receptor binding, hormone activity, and hormone binding, were analyzed. These key categories were significantly enriched following nerve injury, reaching a peak at about 12 h PNI (Figure [3B](#F3){ref-type="fig"}). Similar to the expression changes related to cellular component categories of synapse (part), the expression changes of differentially expressed genes involved in two categories of neurotransmitter receptor activity and neurotransmitter binding also showed a curved shape (Figure [3B](#F3){ref-type="fig"}).

![**Enriched GO molecular functions of differentially expressed genes. (A)** GO molecular functions with a *p* \< 0.05 were labeled in red while molecular functions with a *p* \> 0.05 were labeled in white. **(B)** The expression profiles of differentially expressed genes involved in several critical molecular functions related with nerve repair and regeneration.](fncel-11-00022-g0003){#F3}

Biological processes related to differentially expressed genes were also annotated by GO analysis. A relatively larger number of significant biological processes with a *p* \< 0.05 were involved, and therefore only top enriched biological processes with a *p* \< 0.001 were displayed in Figure [4A](#F4){ref-type="fig"}. In an early stage (0.5 and 1 h PNI), few biological process categories were enriched. Starting from 6 h PNI, many biological process categories, such as response to wounding, defense response, inflammatory response, immune response, regulation of apoptosis, and regulation of cell death, were enriched (Figures [4A,B](#F4){ref-type="fig"}). These enriched categories might contribute to the onset of Wallerian degeneration. In the later stage, especially at 4 weeks PNI, several biological process categories, such as homeostatic process, chemical homeostasis, cellular homeostasis, cellular ion homeostasis, and ion homeostasis, were significantly enriched, suggesting that Wallerian degeneration was close to the end and a homeostatic state was reached (Figure [4A](#F4){ref-type="fig"}).

![**Enriched GO biological processes of differentially expressed genes. (A)** GO biological processes with a *p* \< 0.001 were labeled in red while biological processes with a *p* \> 0.001 were labeled in white. **(B)** The expression profiles of differentially expressed genes involved in several critical biological processes during nerve repair and regeneration.](fncel-11-00022-g0004){#F4}

Critical signaling pathways involved in Wallerian degeneration
--------------------------------------------------------------

GO analysis provided an overall insight into the cellular and molecular regulation of Wallerian degeneration. KEGG analysis was further performed to identify critical signaling pathways in the distal nerve stump at each time point (Figure [5](#F5){ref-type="fig"}). Two signaling pathways, cytokine-cytokine receptor interaction and neuroactive ligand-receptor interaction, were significantly involved in phases I and II of Wallerian degeneration, respectively. Cytokine-cytokine receptor interaction was activated as early as 1 h PNI and kept activated until 12 h PNI, while neuroactive ligand-receptor interaction was activated from 6 h to 4 weeks PNI. Besides these two pathways, calcium signaling pathway, insulin signaling pathway, Jak-STAT signaling pathway, and MAPK signaling pathway were also significantly involved in the process of Wallerian degeneration.

![**Enriched KEGG pathways of differentially expressed genes**. KEGG pathways with a *p* \< 0.05 are listed. The X-axis showed Rich Factor, the ratio of differentially expressed gene numbers to all gene numbers annotated in the KEGG pathway. The number of differentially expressed gene annotated in the specific KEGG pathway was expressed as the size of the circle. The *p*-value of KEGG pathway was corrected to *Q*-value ranging from 0 to 1.](fncel-11-00022-g0005){#F5}

Regulatory networks of differentially expressed transcription factors during Wallerian degeneration
---------------------------------------------------------------------------------------------------

Differentially expressed transcription factors were specifically screened out as they might play central roles in the regulation of Wallerian degeneration and robustly affect diverse biological processes. IPA database was further used to construct the regulatory networks of differentially expressed transcription factors (Figure [6A](#F6){ref-type="fig"}). Consistent with previous results that few changes were observed in an early stage of Wallerian degeneration (Figure [1A](#F1){ref-type="fig"}), there were no differentially expressed transcription factors at 0.5 and 1 h PNI. Starting from phase II, the expression levels of several transcription factors were significantly changed. At 6 h PNI, FOSL1, BCL11A, SMAD3 were up-regulated, while SS18L1 and CASKIN1 were down-regulated. Moreover, these three transcription factors initiated the cascade sequence of transcriptional factors to accompany and modulate Wallerian degeneration. The temporal expression profiles of FOSL1 and SS18L1 were further validated by qPCR. Results from qPCR analysis were in agreement with the data from microarray analysis (Figure [6B](#F6){ref-type="fig"}).

![**Cascade network of differentially expressed transcription factors. (A)** The interaction network of up-regulated (red) transcription factors and down-regulated (green) transcription factors at each time point following nerve transection. **(B)** qPCR determination for mRNA expressions of FOSL1 and SS18L1. The relative level was normalized to GAPDH. The data, obtained from 3 independent experiments, are expressed as means ± SEM. ^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, and ^\*\*\*^*p* \< 0.001.](fncel-11-00022-g0006){#F6}

Discussion {#s4}
==========

Wallerian degeneration consists of a series of complicated cellular and molecular events and plays important roles in responses to nerve injury and perhaps to regeneration. Since its description by Waller in 1850 (Waller, [@B28]), many morphological studies have described events in Wallerian degeneration. In the current study, we systematically examined differentially expressed genes in the distal sciatic nerve stump at different time points following transection, aiming to have a better understanding of Wallerian degeneration from the genetic aspect.

Hierarchical clustering, Euclidean distance calculation, and PCA analysis results showed that the period of 0 h to 4 weeks PNI could be divided to three distinct phases by similarity of gene expression profiles among different time points. GO annotation was used to correlate the differentially expressed genes with cellular components, molecular functions, and biological processes. Enriched categories of cellular components, molecular functions, and biological processes at different time points were further studied in terms of three transcriptional phases.

In phase I, only a few genes were differentially expressed, and not many GO categories were altered correspondingly. GO analysis also indicated that the most remarkable change in this phase might be cellular fraction enrichment. Accordingly, observations from photomicrograph suggested that neurofilament and myelin disintegrate into fragments at 1 h post injury (Sta et al., [@B26]). In phase II, relatively more numerous genes were differentially expressed, and more numerous GO categories were involved. Stimulus response-associated biological processes, such as response to wounding, defense response, inflammatory response, immune response, regulation of apoptosis, and regulation of cell death, were significantly activated. Increased inflammatory and immune response identified by bioinformatic analysis were consistent with morphological observations that phagocyte accumulated and infiltrated in the injured nerves (Sta et al., [@B26]). Activity/binding of cytokine, growth factor, chemokines, and hormone were significantly activated in this phase. In phase III, many biological processes were first activated, and then gradually declined to a homeostatic state. Taken together, the results showed that the time period PNI might be divided into three different phases, which corresponded to the formation and characteristics of Wallerian degeneration. In short, acute response to nerve injury, pre-formation of Wallerian degeneration, and comprehensive execution of Wallerian degeneration occurred in phase I (0--1 h PNI), phase II (6--24 h PNI), and phase III (within 4 days to 4 weeks PNI), respectively (Figure [7](#F7){ref-type="fig"}).

![**Schematic diagram of the transcriptional changes during Wallerian degeneration**.](fncel-11-00022-g0007){#F7}

Enriched signaling pathways during Wallerian degeneration were also examined by KEGG analysis. Consistent with our previous studies (Li et al., [@B17], [@B18]; Yao et al., [@B31]), cytokine-cytokine receptor interaction was activated in an early stage of Wallerian degeneration. Neuroactive-ligand receptor interaction was also significantly activated. Elevated activity of neuroactive-ligand receptor interaction signaling pathway has been linked with Parkinson\'s disease, a neurodegenerative disease (Hamza et al., [@B10]; Kong et al., [@B14]). Our current finding that neuroactive-ligand receptor interaction signaling pathway was activated during Wallerian degeneration might provide some preliminary evidence for the similarity between Wallerian degeneration and neurodegenerative disease. Besides these two most enriched signaling pathways, some other enriched pathways were also identified; for example, calcium signaling pathway. Calcium has long been implicated in Wallerian degeneration (Schlaepfer, [@B25]). Wld^s^ mouse exhibits an increased mitochondrial flux and an enhanced mitochondrial calcium buffering compared with normal mouse, suggesting the important roles of calcium in Wallerian degeneration (Coleman, [@B4]; Avery et al., [@B1]; Freeman, [@B6]). The current study, from the genetic level, demonstrated the involvement of calcium signaling in Wallerian degeneration, especially at 12 and 24 h PNI.

Transcription factors are DNA-binding proteins able to control the transcription rate of target genes (Karin, [@B13]; Latchman, [@B15]). Differentially expressed transcription factors mediate various physiological and pathological conditions through affecting the expression levels of target genes. They are usually incorporated in activation of multiple intracellular signaling cascades, interlinking to create the complex cascade networks (Patodia and Raivich, [@B22]). Based on their significance, differentially expressed transcription factors and their cascade networks were investigated in the current study. Further studies will be performed to determine the biological effects of these transcription factors on Wallerian degeneration.

Conclusions {#s5}
===========

In the current study, we generated an integrated global view of gene expression patterns at the distal nerve stump following peripheral nerve injury. Bioinformatic analysis further enabled us to divide the phases and gain a comprehensive view of molecular changes during Wallerian degeneration.
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###### 

**Gene expression profiles at the distal stumps at each time point following sciatic nerve transection**. Gene expression values at each time point were listed and their expressions at 0.5, 1, 6, 12, 24 h, 4 days, 1, 2, 3, and 4 weeks post nerve injury were compared with 0 h control. Genes with the absolute value of fold change \> 2 (the absolute value of log~2~FC \> 1) and an adjusted p-value \< 0.05 were considered as differentially expressed.

###### 

Click here for additional data file.
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